CompletedPhase 4NCT02080559

Investigating the Immune Response to 4CMenB in Infants

Studying Meningococcal meningitis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Oxford
Principal Investigator
Andrew J Pollard, PhD
Oxford Vaccine Group, University of Oxford
Intervention
4CMenB(biological)
Enrollment
187 target
Eligibility
All sexes
Timeline
2014 – 2018

Study locations (1)

Collaborators

Public Health England · Imperial College London · Novartis Vaccines · European Commission

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02080559 on ClinicalTrials.gov

Other trials for Meningococcal meningitis

Additional recruiting or active studies for the same condition.

See all trials for Meningococcal meningitis →

← Back to all trials